about
The Neurobiology of the Switch Process in Bipolar DisorderA randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depressionThe role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesisChallenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved TherapeuticsClinical and biochemical manifestations of depression: relation to the neurobiology of stressDeveloping biomarkers in mood disorders research through the use of rapid-acting antidepressantsCOMT Met (158) modulates facial emotion recognition in bipolar I disorder mood episodesAntidepressant Efficacy of Adjunctive Aerobic Activity and Associated Biomarkers in Major Depression: A 4-Week, Randomized, Single-Blind, Controlled Clinical TrialNew therapeutic targets for mood disordersIncreased uric acid levels in drug-naïve subjects with bipolar disorder during a first manic episodeBimodal effect of lithium plasma levels on hippocampal glutamate concentrations in bipolar II depression: a pilot study.The bipolar depression electrical treatment trial (BETTER): design, rationale, and objectives of a randomized, sham-controlled trial and data from the pilot study phase.The CACNA1C risk allele rs1006737 is associated with age-related prefrontal cortical thinning in bipolar I disorder.Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist.The immunology of bipolar disorderOxidative stress in early stage Bipolar Disorder and the association with response to lithiumCytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial.BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial.Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine.Lithium increases nitric oxide levels in subjects with bipolar disorder during depressive episodes.Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effectsA kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors.Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept studyHistone deacetylases and mood disorders: epigenetic programming in gene-environment interactionsDoes gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder?Cytokines in bipolar disorder: paving the way for neuroprogression.Baseline vitamin B12 and folate levels do not predict improvement in depression after a single infusion of ketamine.Plasma cortisol in first episode drug-naïve mania: differential levels in euphoric versus irritable moodThe impact of the CACNA1C risk allele on limbic structures and facial emotions recognition in bipolar disorder subjects and healthy controls.Does lithium prevent Alzheimer's disease?Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorderMultiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approachGlutamatergic modulators: the future of treating mood disorders?Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression.Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorderKetamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review.New targets for rapid antidepressant action.Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action.The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder.A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania.
P50
Q22241114-3CFD5555-CC30-48C7-A301-E28F60433F82Q24630153-6894DBCD-447B-421E-8FAB-499283FF365BQ24651407-C0C6CA55-FF92-421D-9C05-0AD77670F9A3Q26782997-ED48D40A-9D58-4F18-8536-4A3485AA4715Q26824899-240E628E-3D31-428F-95CB-974C4CE623E5Q26996955-6F15E3A3-3D09-46AF-859A-A4A48F36F7ADQ28256792-D475338B-4F69-425B-9552-8BC2757D2F3EQ28551850-5FACEC0E-045C-4DBA-A382-FDD6FD98BC64Q28743068-60D6B608-14D4-41C5-BA58-78A3BC607B09Q30039672-6C12565D-3FE3-4BCC-8114-335C1CB3E2E3Q30880781-080F20C6-3AAD-4722-B0CA-04F678CC08DDQ30933842-18F270FF-488B-40F5-AF86-69A400A494E9Q33635674-EEEBCCC7-C06D-4691-8F19-A00587DB8286Q33643067-A32D1F78-E92A-4951-A6E9-E7CED37DD553Q33698965-26DC3E7C-83AD-40F3-95C0-BAC3CAC26F58Q33738259-1B71285A-6372-4D39-B708-7E8E7EE2AB63Q33842988-C706AD46-AA37-4669-B879-00211DC910CBQ33842993-D4A3C339-4442-4C1C-945F-8FA9C0F9BA8BQ33848833-F889BBA3-50F5-4C43-81BF-8C17119DA3C0Q33854554-C76DF5C8-985A-4513-9F68-DA461ADFBCEEQ33929918-5F2FC5CD-A095-418C-86C7-7BE09CC2153BQ33953387-23A615B9-5246-43A6-9AA7-9516CF7DF8ABQ34119673-AD18167F-A426-4880-90C2-5EBCCD0451EEQ34144718-CF46CF57-5ECA-483C-A9CE-389866B03E0FQ34203814-94FCB6DE-070A-4328-B5CE-EA2E58202E98Q34233926-DA6A57B8-2C11-49C8-82D1-DAA3E9B38426Q34241455-5D1402A9-2B61-40E5-BC09-835313AACC16Q34252020-F8919E8F-29AE-4C18-8CCA-FB47C9B4165EQ34264924-9C0FDFDA-21C8-4569-8B62-26411412A40FQ34268138-7D6E2CF5-92B4-4D81-852C-56EFC42DA652Q34268156-7F678C35-F84B-432D-8947-32742BAC521FQ34268501-066E8F12-EC62-4BB3-937F-D3E4EFE73E4CQ34398007-45DFD7C5-019A-45AD-B335-9343FED27F79Q34442861-54A0570A-5199-449A-8475-C66215FB3C46Q34451408-59176C28-AA98-4A42-A846-1BDBD5BF11D4Q34475595-2F272984-924F-451F-9122-E25A71D4F1DDQ34507177-7436D625-5A24-4FF3-B96C-7E423CE3F369Q34522617-9EB727D4-3FEC-4AE7-9D2C-6BC0435860E8Q34557784-10630812-4836-4FA8-B3BC-C42925B59C48Q34595181-D526955C-5F65-4CB5-B12D-C4E1C1513369
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rodrigo Machado-Vieira
@ast
Rodrigo Machado-Vieira
@en
Rodrigo Machado-Vieira
@es
Rodrigo Machado-Vieira
@nl
type
label
Rodrigo Machado-Vieira
@ast
Rodrigo Machado-Vieira
@en
Rodrigo Machado-Vieira
@es
Rodrigo Machado-Vieira
@nl
prefLabel
Rodrigo Machado-Vieira
@ast
Rodrigo Machado-Vieira
@en
Rodrigo Machado-Vieira
@es
Rodrigo Machado-Vieira
@nl
P106
P1153
57200235853
6602688282
P21
P31
P496
0000-0002-4830-1190